One platform comparison of solubilization potential of dendrimer with some solubilizing agents

References

• Jain NK, Tekade RK. Drug delivery strategies for poorly water-soluble drugs. Kent, UK: Wiley Blackwell Publisher; 2012:373–99
   Google Scholar
• Mohanachandran PS, Sindhumol PG, Kiran TS. Enhancement of solubility and dissolution rate: an overview. Pharmacie Globale Int J Comprehensive Pharm 2010;4:1–10
   Google Scholar
• Gajbhiye V, Palanirajan VK, Tekade RK, Jain NK. Dendrimers as therapeutic agents: a systematic review. J Pharm Pharmacol 2009;61:989–1003
   PubMed Web of Science ®Google Scholar
• Shukla M, Rathore P, Jain A, Nayak S. Enhanced solubility study of glipizide using different solubilization techniques. Int J Pharmacy Pharm Sci 2010;2:46–8
   Google Scholar
• Szejtli J. Cyclodextrins and their inclusion complexes. Budapest: Akademiai Kiado; 1982
   Google Scholar
• Loftsson T, Fridriksdottir H, Olafsdottir B, Gudmundson O. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm Nord 1991;3:215–17
   Google Scholar
• Choi HG, Kim DD, Jun HW, et al. Improvement of dissolution and bioavalability of nitrendipine by inclusion in hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 2003;29:1085–94
   PubMed Web of Science ®Google Scholar
• Youngren SR, Tekade RK, Gustilo B, et al. STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells. BioMed Res Int 2013;2013:858946
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Okagaki T, Narisawa S, et al. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int J Pharm 1998;160:11–19
   Web of Science ®Google Scholar
• Gajbhiye V, Kumar PV, Tekade RK, Jain NK. Pharmaceutical and biomedical potential of pegylated dendrimers. Curr Pharm Des 2007;13:415–29
   Web of Science ®Google Scholar
• Tekade RK, Chougule MB. Formulation development and evaluation of hybrid nanocarrier for cancer therapy: taguchi orthogonal array based design. BioMed Research Int 2013;2013:712678
   PubMed Web of Science ®Google Scholar
• Ikeda K, Tomida H, Yotsuyanagi T. Micellar interaction of tetracycline antibiotics. Chem Pharm Bull 1977;25:1067–71
   PubMed Web of Science ®Google Scholar
• Martin A, Bustamante P. Physical pharmacy. 4th ed. Philadelphia: Lea and Febiger; 1993:410–11
   Google Scholar
• Dwivedi P, Tekade RK, Jain NK. Nanoparticulate carrier mediated intranasal delivery of insulin for the restoration of memory signaling in alzheimer’s disease. Curr Nanosci 2013;9:46–55
   Web of Science ®Google Scholar
• Maheshwari RGS, Tekade RK, Sharma PA, et al. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J 2012;20:161–70
   PubMed Web of Science ®Google Scholar
• Kurmi BD, Kayat J, Gajbhiye V, et al. Micro- and nanocarrier-mediated lung targeting. Expert Opin Drug Deliv 2010;7:781–94
   PubMed Web of Science ®Google Scholar
• Kayat J, Gajbhiye V, Tekade RK, Jain NK. Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine 2011;7:40–9
   PubMed Web of Science ®Google Scholar
• Chauhan AS, Sridevi S, Chalasani KB, et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release 2003;90:335–43
   PubMed Web of Science ®Google Scholar
• Thakur S, Tekade RK, Kesharwani P, Jain NK. The effect of polyethylene glycol spacer chain length on the tumor targeting potential of folate modified PPI dendrimers. J Nanoparticle Res 2013;15:1625–40
   Web of Science ®Google Scholar
• Kesharwani P, Gajbhiye V, Tekade RK, Jain NK. Evaluation of dendrimer safety and efficacy through cell line studies. Curr Drug Targets 2011;12:1478–97
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 2014;39:268–307
   Google Scholar
• Gu L, Wu Zh, Qi X, et al. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. Pharm Dev Technol 2013;18:1051–7
   PubMed Web of Science ®Google Scholar
• Kalhapure RS, Kathiravan MK, Akamanchi KG, Govender T. Dendrimers – from organic synthesis to pharmaceutical applications: an update. Pharm Dev Technol 2013;10:1687–98
   Google Scholar
• Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995;332:1004–14
   PubMed Web of Science ®Google Scholar
• Panchagnula R. Pharmaceutical aspects of Paclitaxel. Int J Pharm 1998;172:1–15
   Web of Science ®Google Scholar
• Dhakad RS, Tekade RK, Jain NK. Cancer targeting potential of folate targeted nanocarrier under comparative influence of tretinoin and dexamethasone. Curr Drug Deliv 2013;10:477–91
   PubMed Web of Science ®Google Scholar
• Tekade RK, Dutta T, Gajbhiye V, Jain NK. Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics. J Microencapsul 2008;15:1–10
   Google Scholar
• Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instr 1965;4:117–22
   Google Scholar
• Kesharwani P, Tekade RK, Jain NK. Spectrophotometric estimation of paclitaxel. Int J Adv Pharm Sci 2011;2:29–32
   Google Scholar
• Tekade RK, Emanuele AD, Elhissi A, et al. Extraction and RP-HPLC determination of taxol in rat plasma, cell culture and quality control samples. J Biomed Res 2013;27:394–405
   Google Scholar
• Singhai AK, Jain S, Jain NK. Evaluation of an aqueous injection of ketoprofen. Pharmazie 1997;52:149–51
   PubMed Web of Science ®Google Scholar
• Gajbhiye V, Kumar PV, Tekade RK, Jain NK. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist. Eur J Med Chem 2008;44:55–66
   Google Scholar
• Kesharwani P, Tekade RK, Gajbhiye V, et al. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine 2011;7:295–304
   PubMed Web of Science ®Google Scholar
• Mahapatra AK, Murthy PN, Biswal S, et al. Solid dispersions with polyethylene glycol 4000 and 20000. Int J Pharm Sci Tech 2010;4:21–31
   Google Scholar
• Prajapati RN, Tekade RK, Gupta U, et al. Dendimer-mediated solubilization, formulation development and in vitro–in vivo assessment of piroxicam. Mol Pharm 2009;6:940–50
   PubMed Web of Science ®Google Scholar
• Szejtli J. Medicinal applications of cyclodextrins. Med Res Rev 1994;14:353–86
   PubMed Web of Science ®Google Scholar
• Ahmed MO. Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug. Eur J Pharm Biopharm 2001;51:221–6
   PubMed Web of Science ®Google Scholar
• Duijvenbode RCV, Borkovec M, Koper GJM. Acid base properties of poly (propylene imine) dendrimers. Polymer 1998;39:2657–64
   Web of Science ®Google Scholar
• Newkome GR, Moorefield CN, Baker GR, et al. Unimolecular micelles. Angew Chem Int Ed 1991;30:1178–80
   Web of Science ®Google Scholar
• Tekade RK, Kumar PV, Jain NK. Dendrimers in oncology: an expanding horizon. Chem Rev 2009;109:49–87
   PubMed Web of Science ®Google Scholar
• Hawker CJ, Wooley KL, Frechet JMJ. Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans 1993;1:1287–97
   Google Scholar
• Stevelmens S, Hest JCM, Jansen JFGA, et al. Synthesis, characterisation and guest-host properties of inverted unimolecular micelles. J Am Chem Soc 1996;118:7398–9
   Web of Science ®Google Scholar
• Gupta U, Agashe HB, Jain NK. Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes. J Pharm Pharmacol Sci 2007;10:358–67
   PubMed Web of Science ®Google Scholar
• Tekade RK, Dutta T, Tyagi A, et al. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 2008;16:758–72
   PubMed Web of Science ®Google Scholar
• Jain K, Kesharwani P, Gupta U, Jain NK. Dendrimer toxicity: let's meet the challenge. Int J Pharm 2010;15:122–42
   Web of Science ®Google Scholar
• Mishra V, Gupta U, Jain NK. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Pharmazie 2010;65:891–5
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Gajbhiye V, Tekade RK, Jain NK. Evaluation of dendrimer safety and efficacy through cell line studies. Curr Drug Targets 2011;12:1478–97
   PubMed Web of Science ®Google Scholar